What it's for (Indications)
- Chloramphenicol ophthalmic preparations are indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by susceptible strains of bacteria.
- These infections commonly include bacterial conjunctivitis, bacterial keratitis, and other anterior segment infections where the broad spectrum of chloramphenicol is appropriate.
- It is effective against a wide range of Gram-positive and Gram-negative bacteria, including but not limited to *Haemophilus influenzae*, *Staphylococcus aureus* (some strains), *Streptococcus pneumoniae*, *Moraxella catarrhalis*, and *Neisseria* species.
- The decision to use chloramphenicol should ideally be guided by microbiological cultures and susceptibility testing, although it may be initiated empirically in certain clinical scenarios when a bacterial etiology is strongly suspected, and considering local resistance patterns.
- Prolonged use without confirmed bacterial infection should be avoided to minimize resistance development.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and children, the typical dosage involves instilling 1 to 2 drops into the conjunctival sac of the affected eye(s) every 3 to 6 hours, or as directed by a healthcare professional. In cases of severe infection, the initial frequency of administration may be increased, potentially to hourly application for the first 24-48 hours, followed by a reduction as the infection improves. Treatment should generally be continued for at least 48 hours after the eye appears normal or symptoms have resolved to prevent relapse, but typically should not exceed 7 to 10 days to mitigate the risk of adverse effects and the emergence of resistant organisms. Patients should be instructed on proper administration technique to prevent contamination of the dropper tip and to avoid contact with the eye or surrounding areas. Adherence to the prescribed dosage regimen is crucial for treatment efficacy. |
Safety & Warnings
Common Side Effects
- Commonly reported side effects associated with chloramphenicol ophthalmic preparations are generally mild and transient, including a stinging, burning, or itching sensation immediately upon instillation.
- Other local reactions may include mild irritation, conjunctival hyperemia (redness), and temporary blurred vision.
- Less common but more serious reactions include hypersensitivity manifestations such as allergic conjunctivitis, contact dermatitis, rash, fever, or angioedema.
- With prolonged use, there is a potential for superinfection with non-susceptible organisms, including fungi, which would necessitate discontinuation and alternative treatment.
- Of significant concern, albeit extremely rare with ophthalmic use due to minimal systemic absorption, is the theoretical risk of serious hematologic toxicities, particularly bone marrow depression, including aplastic anemia.
- Patients should be advised to report any unusual bleeding, bruising, fatigue, or signs of systemic illness immediately.
Serious Warnings
- Black Box Warning: Serious Warnings: Potential for Serious Blood Dyscrasias (Aplastic Anemia) While ophthalmic chloramphenicol formulations do not typically carry a formal FDA Black Box Warning, it is imperative to acknowledge the well-established and severe risk of serious and fatal blood dyscrasias, most notably aplastic anemia, associated with systemic chloramphenicol administration. This adverse effect is dose-related with prolonged systemic exposure, but an idiosyncratic, irreversible, and often fatal aplastic anemia can occur even after short-term systemic exposure or with minimal systemic absorption. Though systemic absorption from ophthalmic preparations is generally considered negligible and the incidence of such events extremely rare with topical ocular use, the theoretical risk, however remote, of idiosyncratic bone marrow depression cannot be entirely dismissed. Consequently, chloramphenicol ophthalmic solution should be reserved for cases where other less toxic antibiotics are ineffective or contraindicated, or when microbiological sensitivity testing confirms its necessity. Patients must be thoroughly informed of this remote but serious risk and advised to immediately report any symptoms such as unusual bleeding, easy bruising, persistent sore throat, fever, or profound fatigue. Routine monitoring of blood counts is not typically warranted for ophthalmic use but should be considered if there are any suspicious systemic symptoms or if prolonged treatment is deemed absolutely necessary.
- Prolonged use of chloramphenicol ophthalmic preparations, similar to other antibiotics, may lead to the overgrowth of non-susceptible organisms, including fungi.
- Should superinfection occur, the use of chloramphenicol should be discontinued, and appropriate alternative therapy initiated.
- Patients should be advised to discontinue treatment and seek medical advice if signs of hypersensitivity, such as rash, itching, or swelling, develop.
- While systemic absorption from ophthalmic administration is generally considered negligible, the potential for serious and fatal bone marrow depression (including aplastic anemia) associated with systemic chloramphenicol therapy necessitates extreme caution.
- Although the risk is exceedingly low with topical ocular use, patients should be monitored for any unexplained bleeding, bruising, fever, or persistent sore throat, and instructed to seek immediate medical attention if these symptoms arise.
- Contact lenses should not be worn during treatment of an ocular infection, and patients should be advised to refrain from wearing them until the infection has completely resolved.
- Proper storage is essential; protect from light and excessive heat.
How it Works (Mechanism of Action)
Chloramphenicol is a broad-spectrum antibiotic that exerts its bacteriostatic effect by inhibiting bacterial protein synthesis. It achieves this by reversibly binding to the 50S ribosomal subunit of susceptible bacteria. This binding specifically interferes with the peptidyl transferase activity, thereby preventing the transfer of amino acids to the growing peptide chain and inhibiting peptide bond formation. The disruption of protein synthesis ultimately halts bacterial growth and multiplication. While primarily bacteriostatic, chloramphenicol can exhibit bactericidal activity against certain highly susceptible organisms or at higher concentrations. Its spectrum of activity encompasses a wide range of Gram-positive and Gram-negative bacteria, as well as anaerobic organisms and some atypical bacteria. Bacterial resistance to chloramphenicol can develop through various mechanisms, most commonly enzymatic inactivation via chloramphenicol acetyltransferase (CAT).
Commercial Brands (Alternatives)
No other brands found for this formula.